Bacterial cell envelope-targeting antibiotics

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Multidrug-resistant bacteria (MDRB) present a critical global health threat.
• Bacterial cell envelopes act as a barrier, hindering antibiotic penetration and efficacy.
• Existing antibiotics face challenges from drug entry and efflux resistance mechanisms.

Purpose of the Study:

• To review novel and established antibiotics targeting bacterial envelopes.
• To explore the potential of targeting unique, underexplored bacterial envelope sites.
• To highlight compounds targeting non-proteinaceous envelope components for reduced resistance development.

Main Methods:

• Comprehensive literature review of envelope-targeting antibiotics.
• Analysis of compounds targeting Gram-positive, Gram-negative, and mycobacterial pathogens.
• Exploration of mechanisms against lipopolysaccharide and prenylated peptidoglycan-precursors.

Main Results:

• Bacterial envelope-targeting is a promising strategy to overcome MDRB.
• Compounds targeting unique envelope sites can diversify antimicrobial mechanisms.
• Non-proteinaceous envelope targets show reduced susceptibility to resistance development.

Conclusions:

• Envelope-targeting antibiotics represent a vital therapeutic approach against MDRB.
• Further research into novel envelope targets can yield new antimicrobial agents.
• This strategy offers a way to bypass common resistance mechanisms and diversify treatment options.